Summary.-Macrophages have been isolated from ascitic and collagenase -dispersed tumours from patients undergoing surgery for ovarian cancer. Macrophages were present in varying proportions in both sites, though the ratio of macrophages to tumour cells was higher in ascites. Marked variation in size (as detected by sedimentation velocity) and cytochemical markers in the macrophages was noted. Highly enriched macrophage fractions were isolated from the ascites and collagenasedispersed solid tumours by a combination of sedimentation velocity and selective EA RFC or adherence techniques. Suppressor activity in the PHA assay was detected in tumour macrophages (4/10 giving>50% inhibition), ascitic macrophages (1/15) and blood monocytes (2/7). Lymphocyte fractions from tumours were unresponsive to PHA and failed to suppress the blood response. Suppressor activity was also present in the purified tumour-cell fraction of 6/14 patients.
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ADCC activity was tested in a few patients. When the activity was determined against the SB target cells, tumour-derived macrophages were inactive, whereas the ascitic fraction showed low but significant activity which averaged much lower than patient blood values. The ADCC assays carried out with the CRC target cell indicated activity within the range of patient blood values in 4/4 ascites and 2/4 tumour macrophage fractions.
Cytotoxicity was also assessed against co-purified autologous tumour cells. Although activity was detected in many of the tests, the results seemed to reflect target cell sensitivity. There appeared to be a correlation between cytotoxicity with test macrophages and normal blood mononuclear cells.
The results indicate that the cytochemical heterogeneity and the variation in size between macrophage fractions is associated with a spectrum of activities.
WE HAVE INITIATED a study of immune competence of the various inflammatory cell types infiltrating primary solid and ascitic ovarian tumours. In the first paper (Haskill et al., 1982a) we outlined the methods used to isolate these cells and characterized the cell markers associated with infiltrating cells from these tumours. Two classes were characterized; 1 sedimented at < 6 mm/h and was similar in size to most blood mononuclear cells; the other was composed of larger, strongly adherent macrophages distinct from blood monocytes, which sedimented with the tumour cells. In the second communication (Haskill et al. 1982b) we investigated effector-cell functions (PHA, ADCC and NK) associated with blood and bloodequivalent inflammatory cells present in both ascitic and solid tumours. The data indicated that all tumour-derived effector-cell tests were markedly depres-sed, whilst only the ascites effector cells marked by FcR were depressed relative to patient blood.
In the present report, we have assessed some of the potential effector-cell activities associated with the large macrophages. Macrophages, distinguished from blood monocytes on the basis of sedimentation velocity, were isolated from both ascites and solid tumours. The results indicate that cytotoxicity, ADCC and suppressorcell tests can be detected in tumourderived macrophages, but there is marked variation between patients.
MATERIALS AND METHODS
The 38 patients in this study have been described earlier (Haskill et al., 1982a) 
RESULTS
Isolation and characterization of ascites and tumour-derived macrophaqes In Haskill et al. (1982a) we described the technique for isolating macrophages from both ascites and collagenase-dispersed ovarian tumours. Macrophages, distinct in size and therefore in sedimentation velocity, were isolated for in vitro functional and cytochemical assays. A summary of the average values for the various markers used in Haskill et al. (1982a) is given in Fig. 1 ing cells were sometimes found in tumourderived material.
Suppression of the PHA response
As tumour-associated macrophages in highly immunogenic animal tumours have previously been shown to possess immunosuppressive activity (Holden et al., 1976) it was of interest to investigate this function in spontaneous human malignancies.
Blood monocytes, ascites and tumourderived macrophages (TuM) were tested for activity in the PHA response of autologous nonadherent blood lymphocytes. For comparison tumour cells as well as tumour-derived lymphocytes (TIL) were used when available. Because the various tumours and ascites fluids contained widely differing numbers of macrophages and lymphocytes, it was impossible to use every effector-cell type in each experiment. However, in each case, more than one cell type from the same patient was used.
The results of a typical experiment in which a variety of effector-cell populations were testsed is given in Fig. 2 . Graded doses of cells were added to 104 nonadherent patient blood lymphocytes. Tumour cells, TIL (which are routinely unresponsive to PHA; Haskill et al., 1982b) ascites-derived macrophages (AscM) and a population of TuM sedimenting as fast as the AscM, failed to suppress the response. However, the slower-sedimenting population of TuM was effective.
Similar experiments were carried out on 18 patients with two or more test populations available. Blood monocyte levels were often so low at time of surgery that these assays were difficult to accumulate data from. The results (Fig. 3) indicated that blood monocytes were sometimes suppressive, as were a lower proportion of AscM. ADCC Activity of AscM and TuM ADCC assays were carried out against either the K-cell sensitive tumour target SB, or the monocyte-sensitive erythroid CRBC target cell. Previously, we reported that the blood mononuclear-cell fraction of these patients is frequently as active as that of normal donors in both these assays (Haskill et al., 1982b) . TuM had significant activity in 2/4 cases against the monocyte-sensitive CRBC target cell (Fig. 4) while being inactive against the K-cell-sensitive SB target cell. The AscM were always active in the CRBC-TNP assay (4/4) but showed generally lower responses in the SB-TNP assay. Macrophage fractions were tested for cytotoxicity against autologous tumour cells in a 20h 51Cr-release assay. Data from the 11 patients in which spontaneous isotope release did not exceed 50% are given in the Table. The results indicate cytotoxicity in many of the tests, usually accompanied by similar activity with both normal blood mononuclear cells and the several TIL fractions used. The low levels of activity the wide variation between patients and the lack of clear-cut differences between normal blood and tumour-associated effector cells, precluded a more in-depth assessment of these data.
DISCUSSION
Macrophages infiltrate a wide variety of both animal and human tumours (for general review, see Witz & Hanna, 1980; Haskill et al., 1978) . Numerous investigations have reported that direct cytotoxicity is associated with macrophages isolated from highly immunogenic rodent tumours (Russell et al., 1980; Herberman et al., 1980; Becker & Haskill, 1980 ) and in at least 1 case, a different type of activity (ADCC) was found to be associated with these macrophages (Key & Haskill, 1981) . Macrophages capable of suppressing mitogen response have also been isolated from a murine tumour (Holden et al., 1976) . To match this heterogeneity of function, there was a similar degree of heterogeneity of cytochemical appearance and size in both TuM from animal (Haskill, 1981) and human tumours (Haskill et al., 1982a) . In few studies has heterogeneity of macrophages been assessed or discussed as an explanation, even partial, for the heterogeneous responses detected with the macrophages isolated from a variety of animal or human tumours Haskill, 1981) .
Functional activity of tumour-derived effector cells had been difficult to document for cells from human tumours. In general, NK-cell function was markedly depressed in human tumours (Vose et al., 1977a; Totterman et al., 1980; Mantovani et al., 1980a; Haskill et al., 1982b) . Specifically cytotoxic T cells have only been detected in a few instances (Vose et al., 1977b; Werkmeister et al., 1979) suggesting that effector-cell function may be difficult to maintain in situ. Few investigators have studied macrophage function in human tumours. Vose (1978) reported cytotoxicity against autologous tumour cells in most TuM. However, the level of cytotoxicity was similar to that of blood monocytes or macrophages isolated from tumour-free lung tissue. Mantovani et al. (1980b) have reported on the activity of macrophages in human ovarian ascites. Ascitic macrophages were similar in activity to blood monocytes in a cytotoxicity assay against both a cell line and a number of ovarian cell lines. Our present studies only briefly touched upon autologous cytotoxicity. The results indicated low and variable levels of isotope release, with little evidence of preferential host activity.
In the present study, we have attempted to assess some functions of macrophages associated with both the tumour and the ascites fluid. Because of the general inactivity of all of the blood-equivalent mononuclear cells associated with FcR in both ascites and tumour sites (Haskill et al., 1 982b) it seemed important to determine whether the FcR+ macrophages were also depressed in activity in suppressor and ADCC tests.
Immunosuppressive macrophages have been associated with the spleens of a variety of animal tumours displaying a spectrum of immunogenicities (Kirchner, 1978; Parthenais & Haskill 1979; Farrar & Elgert, 1978; Glaser et al., 1975) . Peripheral-blood monocytes of some cancer patients have also been reported to be immunosuppressive, and have been suggested as one of the explanations for depressed in vitro immune function in these patients (Jerrells et al., 1978) . There has been only one report of immunosuppressive macrophages in situ (Holden et at., 1976) and because this was a highly immunogenic tumour, it seemed worth investigating whether such effector cells were present in spontaneous human tumours.
Our present results indicate that macrophage suppressor-cell activity, previously shown to be associated with TuM in the highly immunogenic MSV model (Holden et al., 1976) can also be detected in some spontaneous human ovarian tumours. While the relevance of such an observation is far from clear, it does indicate that functionally active macrophages exist in human tumours. Not all TuM were immunosuppressive. Adequate cell numbers were not always available to carry out ADCC assays in each of these suppressor experiments, to determine whether a lack of one activity was associated with the presence of another. Neither was it possible to collect enough data to determine whether activity in the tumourderived fraction was necessarily associated with activity in the blood monocyte or ascites fractions. The preliminary data reported here do suggest that several functionally distinct macrophage subsets exist in situ. This is particularly obvious when the sedimentation-velocity profiles in Haskill et al. (1982a) are considered. In particular the data in Fig. 2 demonstrate that only 1 of 3 macrophage fractions was immunosuppressive.
Ascitic macrophages were infrequently active in the suppressor-cell assay, though their activity in the ADCC/(CRC) assay indicated that these cells were functionally active. In view of the heterogeneity of macrophages in terms of sedimentation velocity and cytochemical markers (Haskill et al., 1982a) 
